跳至主要内容
临床试验/EUCTR2011-004177-83-NL
EUCTR2011-004177-83-NL进行中(未招募)不适用

Boosting the oxytocin system in acute trauma: The effectiveness of intranasal oxytocin treatments and stimulation of social support on preventing trauma related psychopathology - Oxytocin and social support as early interventions in acute trauma

Academic Medical Center0 个研究点开始时间: 2011年9月7日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ?Presentation at the Trauma Unit or Emergency Department after a potential traumatic event, according to PTSD A1 criterion in the DSM-IV
  • ?Trauma Screening Questionnaire (TSQ) > 5 between 24 and 72 hours after trauma exposure
  • ?Age 18 – 65 years
  • ?Significant other (i.e. best friend, partner or family member) willing to join the social support intervention
  • ?Capable to read and comprehend either the Dutch or English language
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 260
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ?Any severe or chronic systemic disease
  • ?Current psychotic, bipolar, substance-related, severe personality disorder, or mental retardation
  • ?Current severe depressive disorder
  • ?Prominent current suicidal risk or homicidal ideation
  • ?Severe cognitive impairment or a history of organic mental disorder
  • ?Evidence of PTSD or depression immediately prior to the index trauma
  • ?History of neurological disorders (e.g., traumatic brain injury, seizure history)
  • ?Reports of ongoing traumatization (e.g., in case of partner violence as index adult trauma)
  • ?Evidence of clinically significant and unstable medical conditions in which OT administration is contra-indicative such as cardiovascular, gastro-intestinal, pulmonary, severe renal, endocrine or hematological disorders, glaucoma, history of epilepsy, or a stroke or myocardial infarction within the past year
  • ?Use of prostaglandins and certain anti-migraine medications (ergot alkaloids)
  • ?Sensitivity or allergy for OT or its components (e.g., methylhydroxybenzoate and propylhydroxybenzoate)
  • ?Impaired consciousness, or amnesia or confusion (due to for example head injury) (Glasgow Coma Scale lower than 13)
  • ?Female participants: pregnancy and breast feeding (NB. Female participants with childbearing potential must have a negative pregnancy test).

研究者

发起方
Academic Medical Center

相似试验